De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Nova Eye Medical Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Tom Spurling
Algemeen directeur
AU$291.1k
Totale compensatie
| Percentage CEO-salaris | 84.3% |
| Dienstverband CEO | 4.2yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 6.1yrs |
| Gemiddelde ambtstermijn bestuur | 6.3yrs |
Recente managementupdates
Recent updates
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%
Sep 22
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)
Aug 06Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward
Apr 18Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?
Mar 26News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts
Jan 19Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce
Dec 27We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate
Sep 03Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified
Apr 17Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?
Dec 16We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully
Aug 27Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | AU$291k | AU$245k | -AU$9m |
| Mar 31 2024 | n/a | n/a | -AU$12m |
| Dec 31 2023 | n/a | n/a | -AU$14m |
| Sep 30 2023 | n/a | n/a | -AU$15m |
| Jun 30 2023 | AU$253k | AU$211k | -AU$15m |
| Mar 31 2023 | n/a | n/a | -AU$13m |
| Dec 31 2022 | n/a | n/a | -AU$11m |
| Sep 30 2022 | n/a | n/a | -AU$9m |
| Jun 30 2022 | AU$311k | AU$191k | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$6m |
| Sep 30 2021 | n/a | n/a | -AU$5m |
| Jun 30 2021 | AU$72k | AU$66k | -AU$4m |
| Dec 31 2020 | n/a | n/a | -AU$9m |
| Sep 30 2020 | n/a | n/a | -AU$10m |
| Jun 30 2020 | n/a | n/a | -AU$10m |
| Dec 31 2019 | n/a | n/a | -AU$6m |
| Sep 30 2019 | n/a | n/a | -AU$6m |
| Jun 30 2019 | AU$328k | AU$306k | -AU$7m |
| Mar 31 2019 | n/a | n/a | -AU$7m |
| Dec 31 2018 | n/a | n/a | -AU$6m |
| Sep 30 2018 | n/a | n/a | -AU$6m |
| Jun 30 2018 | AU$329k | AU$300k | -AU$5m |
Compensatie versus markt: De totale vergoeding ($USD 200.58K ) Tom } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 313.13K ).
Compensatie versus inkomsten: De vergoeding van Tom is gestegen terwijl het bedrijf verliesgevend is.
CEO
Tom Spurling (62 yo)
4.2yrs
Tenure
AU$291,117
Compensatie
Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman | 23.3yrs | AU$254.51k | geen gegevens | |
| MD & Executive Director | no data | AU$291.12k | 0.37% A$ 152.1k | |
| Chief Financial Officer | no data | geen gegevens | geen gegevens | |
| Investor Relations | no data | geen gegevens | geen gegevens | |
| Chief Commercial Officer | no data | geen gegevens | geen gegevens | |
| Chief Medical Officer | 6yrs | geen gegevens | geen gegevens | |
| President of Ellex iTrack | 6.3yrs | geen gegevens | geen gegevens | |
| Company Secretary | 4.3yrs | geen gegevens | geen gegevens | |
| Vice President of Global Service | no data | AU$143.97k | geen gegevens | |
| Advisor to the Board | no data | AU$243.97k | geen gegevens |
6.1yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van EYE is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman | 23.3yrs | AU$254.51k | geen gegevens | |
| MD & Executive Director | 4.2yrs | AU$291.12k | 0.37% A$ 152.1k | |
| Independent Director | 11.4yrs | AU$55.50k | 0.59% A$ 241.4k | |
| Non Executive Director | 6.3yrs | AU$61.05k | 0.0087% A$ 3.6k | |
| Independent Director | 1.9yrs | AU$61.05k | 0.24% A$ 100.0k |
6.3yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van EYE wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.3 jaar).